2025-2033 年日本照護端診斷市場報告（按產品類型、平台、處方模式、最終用戶和地區分類）

2024 年，日本床邊診斷IMARC Group規模達到 17 億美元。癌症、糖尿病和心血管問題等慢性病的盛行率不斷上升，人們對社區診所、藥局和家庭環境的偏好轉變，以及人口老化的擴大是推動市場發展的一些關鍵因素。

照護端診斷 (POCD) 是指在患者護理現場或附近進行的醫學測試，為立即臨床決策提供快速結果。它方便用戶使用，只需對醫療保健專業人員進行最少的培訓，並涵蓋針對傳染病、慢性病、懷孕和各種生物標記的廣泛測試。它提高了醫學檢測的可及性，特別是在資源有限的環境中。它有助於防止傳染病在社區或醫療機構內傳播。它減少了多次臨床就診的需要，提供了便利性並可能降低醫療成本。它有助於根據即時資料管理和調整治療計劃。它廣泛用於急診醫學，以快速評估和診斷危急情況，例如心臟事件、敗血症或呼吸窘迫。

日本照護端診斷市場趨勢：

癌症、糖尿病和心血管問題等慢性病的盛行率不斷上升，加上對定期監測和立即醫療照護的需求不斷增加，是推動日本 POCD 需求的主要因素之一。此外，人口老化的擴大和住院率的上升也促進了市場的成長。同時，快速的城市化、個人生活方式的改變以及肥胖和高血壓等生活方式相關疾病風險的上升正在推動該國市場的發展。 POCD 有助於及時監控和管理這些情況，從而導致對 POC 測試設備的需求更大。除此之外，人們對社區診所、藥局和家庭環境的偏好正在對市場產生正面影響。此外，國家管理當局持續關注醫療保健產業的現代化，這提供了良好的市場前景。他們正在實施多項措施並提供優惠的報銷率，以鼓勵醫療保健服務中的技術整合。此外，日本強大的技術部門積極致力於小型化和自動化，確保 POCD 符合可靠性和可用性的最高標準。同時，日本醫療保健提供者、診斷公司和研究機構之間不斷加強的合作正在為市場創造積極的前景。這些合作夥伴關係促進創新，並支持針對特定醫療條件開發客製化的 POC 解決方案。此外，向預防性醫療保健和早期疾病檢測的日益轉變正在推動市場成長。 POC 診斷使個人能夠定期監測自己的健康狀況，促進積極主動的醫療保健方法並減輕醫療機構的負擔。日本民眾對定期健康檢查重要性的認知不斷增強，這對市場產生了積極影響。

日本照護端診斷市場細分：

產品類型見解：

• 血糖監測套件
• 心臟代謝監測套件
• 妊娠和生育力測試套件
• 傳染病檢測試劑盒
• 膽固醇試紙
• 血液學檢測試劑盒
• 其他

平台洞察：

• 側流分析
• 量油尺
• 微流控
• 分子診斷
• 免疫測定

處方模式見解：

• 基於處方的測試
• 場外測試

最終使用者見解：

• 專業診斷中心
• 居家護理
• 研究實驗室
• 其他

競爭格局：

市場研究報告也對競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

• 到目前為止，日本床邊診斷市場的表現如何，未來幾年又會如何表現？
• COVID-19 對日本護理診斷市場有何影響？
• 日本護理診斷市場依產品類型分類是怎樣的？
• 日本床邊診斷市場基於平台的詳細情形如何？
• 日本即時診斷市場基於處方模式的細分是什麼？
• 日本床邊診斷市場以最終用戶分類是怎樣的？
• 日本護理診斷市場價值鏈的各個階段是什麼？
• 日本護理診斷的關鍵促進因素和挑戰是什麼？
• 日本床邊診斷市場的結構如何？
• 日本床邊診斷市場的競爭程度如何？

本報告回答的關鍵問題：

• 到目前為止，日本床邊診斷市場的表現如何，未來幾年又會如何表現？
• COVID-19 對日本護理診斷市場有何影響？
• 日本護理診斷市場依產品類型分類是怎樣的？
• 日本床邊診斷市場基於平台的詳細情形如何？
• 日本即時診斷市場基於處方模式的細分是什麼？
• 日本床邊診斷市場以最終用戶分類是怎樣的？
• 日本護理診斷市場價值鏈的各個階段是什麼？
• 日本床邊診斷的關鍵促進因素和挑戰是什麼？
• 日本床邊診斷市場的結構如何？
• 日本床邊診斷市場的競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

• 研究目的
• 利害關係人
• 數據來源
  • 主要來源
  • 二手資料
• 市場預測
  • 自下而上的方法
  • 自上而下的方法
• 預測方法

第 3 章：執行摘要

第 4 章：日本照護端診斷市場 - 簡介

• 概述
• 市場動態
• 產業動態
• 競爭情報

第 5 章：日本照護端診斷市場格局

• 歷史與當前市場趨勢（2019-2024）
• 市場預測（2025-2033）

第 6 章：日本照護端診斷市場 - 細分：按產品類型

• 血糖監測套件
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 心臟代謝監測套件
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 妊娠和生育力測試套件
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 傳染病檢測試劑盒
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 膽固醇試紙
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 血液學檢測試劑盒
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 其他
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）

第 7 章：日本照護端診斷市場 - 細分：按平台分類

• 側流分析
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 量油尺
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 微流控
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 分子診斷
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 免疫測定
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）

第 8 章：日本照護端診斷市場 - 細分：依處方模式

• 基於處方的測試
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 場外測試
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）

第 9 章：日本照護端診斷市場 - 細分：按最終用戶分類

• 專業診斷中心
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 居家護理
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 研究實驗室
  • 概述
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）
• 其他
  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）

第 10 章：日本照護端診斷市場 - 競爭格局

• 概述
• 市場結構
• 市場參與者定位
• 最佳制勝策略
• 競爭儀表板
• 公司評估象限

第 11 章：關鍵參與者簡介

• Company A
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company B
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company C
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company D
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events
• Company E
• Business Overview
• Product Portfolio
• Business Strategies
• SWOT Analysis
• Major News and Events

第 12 章：日本照護端診斷市場 - 產業分析

• 促進因素、限制因素和機會
  • 概述
  • 促進要素
  • 限制
  • 機會
• 波特五力分析
  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅
• 價值鏈分析

第 13 章：附錄

Japan point of care diagnostics market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2033, exhibiting a growth rate (CAGR) of 9.2% during 2025-2033. The increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular problems, shifting preferences towards community clinics, pharmacies, and home settings, and the expanding aging population represent some of the key factors driving the market.

Point of care diagnostics (POCD) refers to medical tests conducted at or near the site of patient care, providing rapid results for immediate clinical decisions. It is user-friendly, requiring minimal training for healthcare professionals and encompasses a broad spectrum of tests for infectious diseases, chronic conditions, pregnancy, and various biomarkers. It enhances accessibility to medical testing, especially in resource-limited settings. It aids in preventing the spread of contagious diseases within communities or healthcare facilities. It reduces the need for multiple clinical visits, offering convenience and potentially lowering healthcare costs. It assists in managing and adjusting treatment plans based on real-time data. It is widely used in emergency medicine to quickly assess and diagnose critical conditions, such as cardiac events, sepsis, or respiratory distress.

Japan Point of Care Diagnostics Market Trends:

The increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular problems, coupled with this rising need for regular monitoring and immediate medical attention, represents one of the primary factors driving the demand for POCD in Japan. Additionally, the expanding aging population and the increasing hospitalization rates are facilitating the market growth. Along with this, rapid urbanization, changing lifestyles of individuals, and the rising risk of lifestyle-related diseases, such as obesity and hypertension, are driving the market in the country. POCD facilitates the timely monitoring and management of these conditions, leading to greater demand for POC testing devices. Apart from this, shifting preferences towards community clinics, pharmacies, and home settings are influencing the market positively. Moreover, governing authorities of the country are continuously focusing on the modernization of the healthcare sector, which is offering a favorable market outlook. They are implementing several initiatives and offering favorable reimbursement rates that encourage technological integration in healthcare services. Furthermore, the robust technology sector of Japan is actively engaged in miniaturization and automation, ensuring that POCDs meet the highest standards of reliability and usability. Along with this, rising collaborations between healthcare providers, diagnostic companies, and research institutions in Japan are creating a positive outlook for the market. These partnerships foster innovation and enable the development of tailored POC solutions for specific medical conditions. In addition, the rising shift towards preventive healthcare and early disease detection is bolstering the market growth. POC diagnostics empower individuals to monitor their health regularly, fostering a proactive approach to healthcare and reducing the burden on healthcare facilities. The growing awareness among the Japanese population about the importance of regular health check-ups is influencing the market positively.

Japan Point of Care Diagnostics Market Segmentation:

Product Type Insights:

• Blood-Glucose Monitoring Kit
• Cardio-Metabolic Monitoring Kit
• Pregnancy and Fertility Testing Kit
• Infectious Disease Testing Kit
• Cholesterol Test Strip
• Hematology Testing Kit
• Others

Platform Insights:

• Lateral Flow Assays
• Dipsticks
• Microfluidics
• Molecular Diagnostics
• Immunoassays

Prescription Mode Insights:

• Prescription-Based Testing
• OTC Testing

End User Insights:

• Professional Diagnostic Centers
• Home Care
• Research Laboratories
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan point of care diagnostics market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan point of care diagnostics market?
• What is the breakup of the Japan point of care diagnostics market on the basis of product type?
• What is the breakup of the Japan point of care diagnostics market on the basis of platform?
• What is the breakup of the Japan point of care diagnostics market on the basis of prescription mode?
• What is the breakup of the Japan point of care diagnostics market on the basis of end user?
• What are the various stages in the value chain of the Japan point of care diagnostics market?
• What are the key driving factors and challenges in the Japan point of care diagnostics?
• What is the structure of the Japan point of care diagnostics market and who are the key players?
• What is the degree of competition in the Japan point of care diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Point of Care Diagnostics Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Point of Care Diagnostics Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Point of Care Diagnostics Market - Breakup by Product Type

• 6.1 Blood-Glucose Monitoring Kit
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Cardio-Metabolic Monitoring Kit
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Pregnancy and Fertility Testing Kit
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Infectious Disease Testing Kit
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)
• 6.5 Cholesterol Test Strip
  • 6.5.1 Overview
  • 6.5.2 Historical and Current Market Trends (2019-2024)
  • 6.5.3 Market Forecast (2025-2033)
• 6.6 Hematology Testing Kit
  • 6.6.1 Overview
  • 6.6.2 Historical and Current Market Trends (2019-2024)
  • 6.6.3 Market Forecast (2025-2033)
• 6.7 Others
  • 6.7.1 Historical and Current Market Trends (2019-2024)
  • 6.7.2 Market Forecast (2025-2033)

7 Japan Point of Care Diagnostics Market - Breakup by Platform

• 7.1 Lateral Flow Assays
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Dipsticks
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Microfluidics
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Molecular Diagnostics
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)
• 7.5 Immunoassays
  • 7.5.1 Overview
  • 7.5.2 Historical and Current Market Trends (2019-2024)
  • 7.5.3 Market Forecast (2025-2033)

8 Japan Point of Care Diagnostics Market - Breakup by Prescription Mode

• 8.1 Prescription-Based Testing
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 OTC Testing
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)

9 Japan Point of Care Diagnostics Market - Breakup by End User

• 9.1 Professional Diagnostic Centers
  • 9.1.1 Overview
  • 9.1.2 Historical and Current Market Trends (2019-2024)
  • 9.1.3 Market Forecast (2025-2033)
• 9.2 Home Care
  • 9.2.1 Overview
  • 9.2.2 Historical and Current Market Trends (2019-2024)
  • 9.2.3 Market Forecast (2025-2033)
• 9.3 Research Laboratories
  • 9.3.1 Overview
  • 9.3.2 Historical and Current Market Trends (2019-2024)
  • 9.3.3 Market Forecast (2025-2033)
• 9.4 Others
  • 9.4.1 Historical and Current Market Trends (2019-2024)
  • 9.4.2 Market Forecast (2025-2033)

10 Japan Point of Care Diagnostics Market - Competitive Landscape

• 10.1 Overview
• 10.2 Market Structure
• 10.3 Market Player Positioning
• 10.4 Top Winning Strategies
• 10.5 Competitive Dashboard
• 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

• 11.1 Company A
  • 11.1.1 Business Overview
  • 11.1.2 Product Portfolio
  • 11.1.3 Business Strategies
  • 11.1.4 SWOT Analysis
  • 11.1.5 Major News and Events
• 11.2 Company B
  • 11.2.1 Business Overview
  • 11.2.2 Product Portfolio
  • 11.2.3 Business Strategies
  • 11.2.4 SWOT Analysis
  • 11.2.5 Major News and Events
• 11.3 Company C
  • 11.3.1 Business Overview
  • 11.3.2 Product Portfolio
  • 11.3.3 Business Strategies
  • 11.3.4 SWOT Analysis
  • 11.3.5 Major News and Events
• 11.4 Company D
  • 11.4.1 Business Overview
  • 11.4.2 Product Portfolio
  • 11.4.3 Business Strategies
  • 11.4.4 SWOT Analysis
  • 11.4.5 Major News and Events
• 11.5 Company E
  • 11.5.1 Business Overview
  • 11.5.2 Product Portfolio
  • 11.5.3 Business Strategies
  • 11.5.4 SWOT Analysis
  • 11.5.5 Major News and Events

12 Japan Point of Care Diagnostics Market - Industry Analysis

• 12.1 Drivers, Restraints, and Opportunities
  • 12.1.1 Overview
  • 12.1.2 Drivers
  • 12.1.3 Restraints
  • 12.1.4 Opportunities
• 12.2 Porters Five Forces Analysis
  • 12.2.1 Overview
  • 12.2.2 Bargaining Power of Buyers
  • 12.2.3 Bargaining Power of Suppliers
  • 12.2.4 Degree of Competition
  • 12.2.5 Threat of New Entrants
  • 12.2.6 Threat of Substitutes
• 12.3 Value Chain Analysis

13 Appendix